T1	Outcomes 42 71	secondary hyperparathyroidism
T2	Outcomes 111 130	safety and efficacy
T3	Outcomes 220 256	secondary hyperparathyroidism (SHPT)
T4	Outcomes 802 822	serum calcium levels
T5	Outcomes 892 915	serum phosphorus levels
T6	Outcomes 1164 1202	2 consecutive decreases in iPTH levels
T7	Outcomes 1225 1234	baseline.
T8	Outcomes 1350 1374	decreases in iPTH levels
T9	Outcomes 1497 1577	hypercalcemia, hyperphosphatemia, and elevated calcium-phosphorus product levels
T10	Outcomes 1668 1744	urinary calcium and phosphorus excretion or deterioration in kidney function
